fashion -WSS

fashion

author：comprehensive 2025-09-06 02:06:10 - browse：95865

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT Report: Patient voices and perspectives

leisure time

WSS

Roche’s Alnylam deal shows drug firms interested in heart drugs

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

A new crop of companies is reshaping the health data economy

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Biden warns of ‘dark winter’ during final presidental debate

entertainment

fashion

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Ending racial health disparities hinges on penalties, political will

At least 13 dead in Texas as scorching temps continue

Tocagen's brain cancer gene therapy trial continues. Investors worry

Novavax promises a turnaround & Lilly roils the obesity market

Winning ticket for $1 billion Powerball jackpot sold in California

Duchenne breakthrough therapy leaves behind pioneering families

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

In age of alternative facts, a scholarly course on calling out crap

STAT Report: Patient voices and perspectives

leisure time

What causes rare myocarditis in young men after Covid vaccines?

I learned firsthand about improving diversity in clinical trials

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

The battle over 'scope creep' and who gets to be called 'doctor'

What it's like to live with paralysis for one psychologist

Winning ticket for $1 billion Powerball jackpot sold in California

explore

focus

leisure time

hotspot